Skip to main content
SpringerLink
Log in

Fast analysis of glibenclamide and its impurities: quality by design framework in capillary electrophoresis method development

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A fast capillary zone electrophoresis method for the simultaneous analysis of glibenclamide and its impurities (IA and IB) in pharmaceutical dosage forms was fully developed within a quality by design framework. Critical quality attributes were represented by IA peak efficiency, critical resolution between glibenclamide and IB, and analysis time. Experimental design was efficiently used for rapid and systematic method optimization. A 35//16 symmetric screening matrix was chosen for investigation of the five selected critical process parameters throughout the knowledge space, and the results obtained were the basis for the planning of the subsequent response surface study. A Box–Behnken design for three factors allowed the contour plots to be drawn and the design space to be identified by introduction of the concept of probability. The design space corresponded to the multidimensional region where all the critical quality attributes reached the desired values with a degree of probability π ≥ 90%. Under the selected working conditions, the full separation of the analytes was obtained in less than 2 min. A full factorial design simultaneously allowed the design space to be validated and method robustness to be tested. A control strategy was finally implemented by means of a system suitability test. The method was fully validated and was applied to real samples of glibenclamide tablets.

Identification of sequence variants in IgG Fc mixtures

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2009) ICH harmonised tripartite guideline, Q8(R2), pharmaceutical development. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva

  2. Orlandini S, Pinzauti S, Furlanetto S (2013) Anal Bioanal Chem 405:443–450

    Article  CAS  Google Scholar 

  3. Rozet E, Lebrun P, Debrus B, Boulanger B, Hubert P (2013) Trends Anal Chem 42:157–167

    Article  CAS  Google Scholar 

  4. De Backer B, Debrus B, Lebrun P, Theunis L, Dubois N, Decock L, Verstraete A, Hubert P, Charlier C (2009) J Chromatogr B 877:4115–4124

    Article  Google Scholar 

  5. Debrus B, Lebrun P, Mbinze Kindenge J, Lecomte F, Ceccato A, Caliaro G, Mavar Tayey Mbay J, Boulanger B, Marini RD, Rozet E, Hubert P (2011) J Chromatogr A 1218:5205–5215

    Article  CAS  Google Scholar 

  6. Debrus B, Guillarme D, Rudaz S (2013) J Pharm Biomed Anal 84:215–223

    Article  CAS  Google Scholar 

  7. Monks KE, Rieger H-J, Molnár I (2011) J Pharm Biomed Anal 56:874–879

    Article  CAS  Google Scholar 

  8. Schmidt AH, Molnár I (2013) J Pharm Biomed Anal 78–79:65–74

    Article  Google Scholar 

  9. Vemić A, Rakić T, Malenović A, Medenica M (2015) J Pharm Biomed Anal 102:314–320

    Article  Google Scholar 

  10. Furlanetto S, Orlandini S, Pasquini B, Del Bubba M, Pinzauti S (2013) Anal Chim Acta 802:113–124

    Article  CAS  Google Scholar 

  11. Orlandini S, Pasquini B, Stocchero M, Pinzauti S, Furlanetto S (2014) J Chromatogr A 1339:200–209

    Article  CAS  Google Scholar 

  12. Orlandini S, Pasquini B, Gotti R, Giuffrida A, Paternostro F, Furlanetto S (2014) Electrophoresis 35:2538–2545

    Article  CAS  Google Scholar 

  13. Orlandini S, Pasquini B, Del Bubba M, Pinzauti S, Furlanetto S (2015) J Chromatogr A 1380:177–185

    Article  CAS  Google Scholar 

  14. Jouyban A, Kenndler E (2008) Electrophoresis 29:3531–3551

    Article  CAS  Google Scholar 

  15. Sweetman SC (ed) (2005) Martindale: the complete drug reference, 34th edn. Pharmaceutical Press, London

  16. Council of Europe (2010) European pharmacopoeia 7.0, vol 2. Council of Europe, Strasbourg

  17. Beaulieu N, Graham SJ, Lovering EG (1993) J AOAC Int 76:962–965

    CAS  Google Scholar 

  18. El Deeb S, Schepers U, Wätzig H (2006) J Sep Sci 29:1571–1577

    Article  Google Scholar 

  19. Khalil SAH, Abu-Baker MAY, Al-Shareef A-H (1998) J Pharm Pharmacol 50:50

    Article  CAS  Google Scholar 

  20. Navaneethan G, Karunakaran K, Elango KP (2011) Lat Am J Pharm 30:1639–1643

    CAS  Google Scholar 

  21. Schepers U, Ermer J, Preu L, Wätzig H (2004) J Chromatogr B 810:111–118

    Article  CAS  Google Scholar 

  22. Takla PG, Joshi SR (1983) J Pharm Biomed Anal 1:189–193

    Article  CAS  Google Scholar 

  23. El Kousy NM (1998) Mikrochim Acta 128:65–68

    Article  Google Scholar 

  24. Bedair MM, Korany MA, Ebdel-hay MA, Gazy AA (1990) Analyst 115:449–453

    Article  CAS  Google Scholar 

  25. Lai EPC, Feng SY (2006) J Chromatogr B 843:94–99

    Article  CAS  Google Scholar 

  26. Maier V, Znaleziona J, Jirovský D, Skopalová J, Petr J, Ševčík J (2009) J Chromatogr A 1216:4492–4498

    Article  CAS  Google Scholar 

  27. Paroni R, Comuzzi B, Arcelloni C, Brocco S, de Kreutzenberg S, Tiengo A, Ciucci A, Beck-Peccoz P, Genovese S (2000) Clin Chem 46:1773–1780

    CAS  Google Scholar 

  28. Núñez M, Ferguson JE, Machacek D, Jacob G, Oda RP, Lawson GM, Landers JP (1995) Anal Chem 67:3668–3675

    Article  Google Scholar 

  29. Roche ME, Oda RP, Lawson GM, Landers JP (1997) Electrophoresis 18:1865–1874

    Article  CAS  Google Scholar 

  30. Strausbauch MA, Xu SJ, Ferguson JE, Nunez ME, Machacek D, Lawson GM, Wettstein PJ, Landers JP (1995) J Chromatogr A 717:279–291

    Article  CAS  Google Scholar 

  31. Ku Y-R, Chag L-Y, Ho L-K, Lin J-H (2003) J Pharm Biomed Anal 33:329–334

    Article  CAS  Google Scholar 

  32. Han FM, Cheng ZY, Cai M, Chen Y (2000) Chin J Chromatogr 18:456–458

    CAS  Google Scholar 

  33. Viana C, Ferreira M, Romero CS, Bortoluzzi MR, Lima FO, Rolim CMB, de Carvalho LM (2013) Anal Methods 5:2126–2133

    Article  CAS  Google Scholar 

  34. Lewis G, Mathieu D, Phan-Tan-Luu R (1999) Pharmaceutical experimental design. Dekker, New York

    Google Scholar 

  35. Herrador MA, Asuero AG, Gonzalez AG (2005) Chemom Intell Lab Syst 79:115–122

    Article  CAS  Google Scholar 

  36. Mathieu D, Nony J, Phan-Tan-Luu R (2011) NEMRODW. LPRAI, Marseille

  37. Umetrics (2013) MODDE 10. Umetrics, Umeå

  38. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005) ICH harmonised tripartite guideline, Q2(R1), validation of analytical procedures: text and methodology. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva

  39. Ishikawa K (1985) What is total quality control? The Japanese way. Prentice Hall, Englewood Cliffs

    Google Scholar 

  40. Loucks DP, van Beek E, Stediger JR, Dijkman JPM, Villars MT (2005) Water resources system planning and management: an introduction to methods, models and applications. UNESCO, Paris

    Google Scholar 

  41. Eriksson L, Johansson E, Kettaneh-Wold N, Wikström C, Wold S (2008) Design of experiments-principles and applications. Umetrics, Umeå

    Google Scholar 

  42. Ermer J, Miller J.H.McB. (Eds.) (2004) Method validation in pharmaceutical analysis-a guide to best practice, Wiley-VCH, Weinheim

Download references

Acknowledgments

The authors thank Ente Cassa di Risparmio di Firenze for financial support and A. Menarini Industrie Farmaceutiche Riunite (Florence, Italy) for the gift of glibenclamide.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Chemistry “U. Schiff”, University of Florence, Via U. Schiff 6, 50019, Sesto Fiorentino, FI, Italy

    Sandra Furlanetto, Serena Orlandini, Benedetta Pasquini, Claudia Caprini, Paola Mura & Sergio Pinzauti

Authors
  1. Sandra Furlanetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serena Orlandini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benedetta Pasquini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudia Caprini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paola Mura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sergio Pinzauti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Sandra Furlanetto or Serena Orlandini.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 258 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furlanetto, S., Orlandini, S., Pasquini, B. et al. Fast analysis of glibenclamide and its impurities: quality by design framework in capillary electrophoresis method development. Anal Bioanal Chem 407, 7637–7646 (2015). https://doi.org/10.1007/s00216-015-8921-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-015-8921-x

Keywords

Search

Navigation